La información al paciente sobre los servicios profesionales farmacéuticos asistenciales de farmacia comunitaria
- Vicente J. Baixauli Fernández
- Fernando Abellán-García Sánchez
- Ana Molinero Crespo
- Rosa Prats Más
- Javier Plaza Zamora
- Leyre Gaztelurrutia Lavesa
- Sara Bellver Beltrán
- María del Mar Arranz Esteban
- José Luis García-Espona Pancorbo
- Javier Cremades Alcaraz
- Noelia Amador Fernández
ISSN: 1885-8619
Any de publicació: 2019
Volum: 11
Número: 3
Pàgines: 22-41
Tipus: Article
Altres publicacions en: Farmacéuticos comunitarios
Resum
The provision of professional pharmaceutical care services (SPFA) to the patient from the community pharmacy must be carried out by observing a series of previous health and legal guarantees that ensure the rights of the patient. Any action in the area of a patient’s health requires his or her free and voluntary consent once he or she had received the appropriate information. This information will, as a general rule, be provided orally (except in the case of invasive procedures, which are the ones with the most serious risks), must be truthful and include at least the purpose and nature of each intervention, its risks and its consequences, and must be communicated to the patient in a way that is understandable and adapted to his or her needs, in a way that helps you make decisions according to your own free will. Thus, in order for the patient to consent to the provision of an SPFA, he must first receive specific information about that service. Although this information could be provided only verbally, as SPFAs are novel services with which the patient is not familiar, it’s advisable to provide it also in writing, as this way ensures that it communicates uniformly, comprehensively, avoiding mistakes and forgetfulness, and also that the patient will have more time to study it at home. This article discusses the minimum information to be provided to patients and users in the provision of SPFA. In addition, it shows, as an example, the information provided to the patient in five of the SPFA that manage the SEFAC e_XPERT® application, as well as an informed consent model which includes all other necessary information which must also be communicated to patient.